124 related articles for article (PubMed ID: 19900316)
1. [Availability of antimalarial agents in Dutch hospitals].
Oudijk JM; Waalewijn BP; Ting L; van Genderen PJ; Overbosch D
Ned Tijdschr Geneeskd; 2009; 153():A462. PubMed ID: 19900316
[TBL] [Abstract][Full Text] [Related]
2. Preparedness for severe malaria.
Heggheim Å; Blomberg B; Mørch K
Tidsskr Nor Laegeforen; 2015 Mar; 135(6):533-5. PubMed ID: 25806760
[TBL] [Abstract][Full Text] [Related]
3. Making antimalarial agents available in the United States.
Magill A; Panosian C
N Engl J Med; 2005 Jul; 353(4):335-7. PubMed ID: 16000347
[No Abstract] [Full Text] [Related]
4. For severe malaria, artesunate is the answer.
Shanks GD
Lancet; 2010 Nov; 376(9753):1621-2. PubMed ID: 21062665
[No Abstract] [Full Text] [Related]
5. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
[TBL] [Abstract][Full Text] [Related]
6. Artesunate v. quinine for severe malaria.
Naidoo P; Saman S
S Afr Med J; 2013 May; 103(5):274. PubMed ID: 23971104
[No Abstract] [Full Text] [Related]
7. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
[TBL] [Abstract][Full Text] [Related]
8. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
[TBL] [Abstract][Full Text] [Related]
10. Artesunate versus quinine for severe falciparum malaria.
Toovey S
Lancet; 2006 Jan; 367(9505):111; author reply 111-2. PubMed ID: 16413873
[No Abstract] [Full Text] [Related]
11. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
Newton PN; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
Clin Infect Dis; 2003 Jul; 37(1):7-16. PubMed ID: 12830403
[TBL] [Abstract][Full Text] [Related]
12. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.
Fungladda W; Honrado ER; Thimasarn K; Kitayaporn D; Karbwang J; Kamolratanakul P; Masngammueng R
Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):59-66. PubMed ID: 9763724
[TBL] [Abstract][Full Text] [Related]
13. Artesunate versus quinine for severe falciparum malaria.
Woodrow CJ; Planche T; Krishna S
Lancet; 2006 Jan; 367(9505):110-1; author reply 111-2. PubMed ID: 16413871
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of quinine-artesunate in an HIV-positive patient with severe falciparum malaria.
Zamidei L; Durval A; Bettocchi D; Luzzio MG; Bartoloni A; Consales G
Minerva Anestesiol; 2010 Jan; 76(1):66-9. PubMed ID: 20125075
[TBL] [Abstract][Full Text] [Related]
15. Suspected quinine resistant P. falciparum severe malaria possibly acquired in Ivory Coast.
Rodríguez-Valero N; Camprubí D; García-Guijarro E; Llenas-García J; Alejo-Cancho I; Cisteró P; Mayor A; Muñoz J; Gupta H
Parasitol Int; 2018 Dec; 67(6):684-687. PubMed ID: 30008393
[TBL] [Abstract][Full Text] [Related]
16. Intravenous artesunate for severe malaria.
Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
[TBL] [Abstract][Full Text] [Related]
17. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
Chotivanich K; Udomsangpetch R; Dondorp A; Williams T; Angus B; Simpson JA; Pukrittayakamee S; Looareesuwan S; Newbold CI; White NJ
J Infect Dis; 2000 Aug; 182(2):629-33. PubMed ID: 10915102
[TBL] [Abstract][Full Text] [Related]
18. Responding to the evidence for the management of severe malaria.
Ford NP; de Smet M; Kolappa K; White NJ
Trop Med Int Health; 2011 Sep; 16(9):1085-6. PubMed ID: 21689220
[No Abstract] [Full Text] [Related]
19. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
Maka DE; Chiabi A; Ndikum V; Achu D; Mah E; Nguefack S; Nana P; Njoumemi Z; Mbacham W; Mbonda E
Malar J; 2015 Oct; 14():429. PubMed ID: 26520401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
